ST
ARRY

Spot Trading’s Array Biopharma Inc ARRY Stock Holding History

Spot Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,598
Closed -$52K – 3527
2017
Q2 		$47K Buy
5,598
+645
+13% +$5.28K ﹤0.01% 2835
2017
Q1 		$44K Buy
+4,953
New +$52.7K ﹤0.01% 2528
2016
Q1 		– Sell
-14,249
Closed -$42.7K – 4265
2015
Q4 		$60K Buy
+14,249
New +$65K ﹤0.01% 2994
2015
Q2 		– Sell
-15,095
Closed -$111K – 4416
2015
Q1 		$111K Buy
+15,095
New +$107K ﹤0.01% 3038
2014
Q3 		– Sell
-100
Closed – – 4907
2014
Q2 		$0 Buy
+100
New +$414 ﹤0.01% 4967

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Spot Trading's ARRY Position: Q3 2017 in Review

Spot Trading sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 5,598 shares — an estimated $52K sold.

Spot Trading first reported a position in ARRY in Q2 2014 and held it in 5 quarters. The position peaked at $111K in Q1 2015. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Spot Trading reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 5,598 Array Biopharma Inc shares in Q3 2017, an estimated $52K.
  • Spot Trading first reported a position in Array Biopharma Inc in Q2 2014 and held it in 5 quarters.
  • Spot Trading's Array Biopharma Inc position peaked at $111K in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.